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One million new breast cancer (BC) cases diagnosed yearly yielded over 400,000 annual deaths. About 
4.4 million women are living with BC worldwide, while 15 million new cases yearly are estimated by 
2020. About 12.15% of women born today would be diagnosed with BC at some time during their 
lifetime. Nigerian women’s BC lifetime risk of 10% accounted for about 16% of all cancer-related deaths. 
Nigeria was ill-equipped in dealing with BC complexities. This paper presented an ethnobotanical 
survey and digitization of Medicinal and Aromatic Plants (MAPs)-based foods for effective BC 
treatment. BC’s risk factors were gathered from General Practitioners. Semi-structured questionnaires 
were randomly administered, in which 70 Physicians and 500 Complementary and Alternative Medicine 
(CAM) practitioners were interviewed. Internet searches were performed on the NCCAM, EBSCO, and 
PubMed databases using BC-related keywords. Specific ethnobotanical data of MAPs having anticancer 
properties were documented through guided fieldworks, local markets, and CAM practitioners’ homes. 
A total of 10% of the studied MAPs yielded Adzuki bean, Asparagus, Broccoli, Burdock, Cabbage, 
Chinese yam, Dandelion, Tomato, Watercress, and Watermelon in effectively treating BC menace. A 
Populated Multimedia-based Medicinal Plants Sustainability Management System was used to address 
MAPs’ extinction challenge with the BC-related MAPs. Orthodox BC treatments have devastating effects 
including temporary infertility. However, eating fruits and vegetables daily significantly reduces BC’s 
risk. 
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INTRODUCTION 
 
Information and communication technology (ICT) has 
become the transformative tool for a new style of global 
development while playing an increasingly important role 
in addressing the global challenges of healthcare. 
Healthcare is an information intensive industry, in which 
reliable and timely information is a critical resource for the 
planning and monitoring of service provision at all levels 
of analysis: (i) organizational, (ii) regional, (iii) national 
and international. Healthcare Information Systems 
(HCISs) have been defined as powerful ICT-based tools 
able to make health care delivery more effective and 
efficient (Locatelli et al., 2012). Health and healthcare 
researches are needed in order to reduce the uncertainty 
associated with the diagnosis, treatment and delivery of 
health care to all of the people in our society who are in 
need of it (Dieppe, 2005). Healthcare aims to achieve the 
best health outcomes in the most efficient manner. 
Today‘s health delivery systems‘ challenge is to increase 
productivity and quality of care without increasing the 
economic costs (de Leiva et al., 2008). Complementary 
and Alternative Medicine (CAM), defined by the National 
Center for Complementary and Alternative Medicine 
(NCCAM), is a group of diverse medical and health care 
systems, practices and products that are not presently 
considered part of conventional medicine. NCCAM, part 
of the National Institutes of Health (NIH), designates five 
major domains of CAM practices: alternative medical 
systems, mind-body interventions, biologically-based 
treatments, manipulative and body-based methods, and 
energy therapies. Each domain comprises numerous 
individual systems and treatments for which the NIH 
provides  research  support  (Heimall  and  Bielory,  2008;  
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Wisneski and Anderson, 2009; Kelvin and Tyson, 2011). 
Patients require treatment and care that work, good 
relationship with practitioner, provision of information, and 
remaining in control of treatment. CAM continually 
attracts patronage due to patients‘ dissatisfaction with 
conventional health care, a desire for greater control over 
one‘s health, and a desire for cultural and philosophical 
congruence with personal beliefs about health and illness 
(Omogbadegun et al., 2011). 
 
Medicinal and aromatic plants (MAPs) 
 
Medicinal and aromatic plants (MAPs) belong to the 
―biologically-based treatments‖ domain of CAM. Industrial 
uses of MAPs include galenicals, health, herbal teas, 
industrial / pharmaceutical auxiliary, intermediates for 
drug manufacture, new drugs, phyto-pharmaceuticals, 
and traditional medicines (Tewari, 2000). MAPs provide 
the raw materials for the pharmaceutical industry where 
drugs derived are made by isolating the active chemicals 
and concentrating them to the medication. Over 80% in 
each of the US public, people in developing countries, 
and Africa‘s population use nonconventional practices 
and complementary medicines adjunctive to conventional 
medical care (Kasirajan et al., 2007; Heimall and Bielory, 
2008; Cho-Ngwa et al., 2010; Li et al., 2011).  
MAPs are increasingly recognized worldwide as an 
alternative source of efficacious and inexpensive 
medications to synthetic chemo-therapeutic compound. 
MAPs are used in treatment and prevention of various 
health problems from simple to complex disease 
situations among rural populations globally, thereby 
improving the quality of life (Elufioye et al., 2012). In 
Nigeria, a country stepped in the use of and belief in 
traditional medicines, the CAM practitioners claim that 
MAPs‘ parts possess various phytochemicals which exhi-
bit diverse pharmacological and biological responses and 
diversities (Idu and Onyibe, 2007; Kayode and Ogunleye,  
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2008; Ekanem and Udoh, 2010; Oladele et al., 2011). 
 
Cancer morbidity 
 
Cancer is a common disease with a devastating impact 
on the physical and psychological well being of patients. 
The diagnosis of cancer brings upon many clinical 
challenges and questions for which clear and simple 
answers are not always provided by modern medicine. 
To date, only limited therapeutic options are available for 
patients with advanced cancer. Cancer, an unrestrained 
proliferation and migration of cells, is a scourge that has 
afflicted mankind since time immemorial. In spite of the 
spectacular advances made by medical science during 
the past century, the treatment of cancer remains an 
enigma. Cancer represents the single largest cause of 
death in both men and women, and is a growing public 
health menace. Each year, about seven million new 
cases are diagnosed, and about five million people die as 
a result of cancer. Prevalence data indicate that currently, 
about 14 million people are suffering from cancer. 
Bearing in mind the level of morbidity that is often 
affiliated with this disease, comprehension of such a high 
incidence is horrifying. The recent shift toward targeted 
therapies has improved substantially patient‘s survival, 
however, relapses are frequent and cure remains rare. 
This led patients and many health care managers to shift 
attention to the holistic approach of traditional medicine 
particularly preparations from herbal products to manage 
and alleviate the disease (Baldi et al., 2007; Alaoui-
Jamali, 2010). Cancer is a major public health problem 
worldwide with millions of new cancer patients diagnosed 
each year and many deaths resulting from this disease. 
Chemotherapy remains the principal mode of treatment 
for various cancers. Breast cancer is a cancer that starts 
in the tissue of the breast. The use of plants or plant 
products for cancer treatment could be due to several 
reasons such as availability of the materials, affordability, 
relatively cheap and little or no side effects. For these 
reasons, World Health Organization (WHO) supports the 
use of traditional medicines provided they are proven to 
be efficacious and non toxic. It is well established that 
plants have been a useful source of clinically relevant 
antitumor compounds. However, traditional Nigerian 
medicinal herbs have been used in the treatment of 
different diseases in the country for centuries. There have 
been claims that some traditional healers in Nigeria can 
successfully treat cancer using herbal preparations 
(Engel et al. 2011).  
Cancer is obviously one of the most common areas 
where demand for alternative treatment is overwhelming 
(Leung, 2007). Cancer arises when cells become 
abnormal and start to multiply out of control. They are 
cells behaving badly. Cells are becoming abnormal all the 
time but in most cases are detected and destroyed by the 
body‘s immune system. Occasionally, our defences fail 
and a cancer results (Matthews et al., 2011).  
 
 
 
 
Cancer is the second leading cause of death 
worldwide. In recent years, efforts have been made to 
synthesize potential anticancer drugs; consequently, 
hundreds of chemical variants of known classes of 
anticancer therapeutic agents have been synthesized. It 
has been recognized that a successful anticancer drug 
should be one, which kills or incapacitates cancer cells 
without causing excessive damage to the normal cells. 
This criterion is difficult, or perhaps, impossible to attain, 
and that is why cancer patients suffer from unpleasant 
side effects while undergoing treatments. Although great 
advancements have been made in the treatment and 
control of cancer progression, significant deficiencies and 
room for improvement remain. A number of undesired 
side effects sometimes occur during chemotherapy. 
While vast amounts of synthetic chemistry have provided 
relatively small improvements over the prototype drugs, 
the synthesis of modified forms of known drugs continues 
as an important aspect of research. Natural therapies, 
such as the use of plant-derived products in cancer 
treatment, may reduce adverse side effects. Currently, a 
few plant products are being used to treat cancer. 
However, a myriad of many plant products exist that have 
shown very promising anti-cancer properties in vitro, but 
are yet to be evaluated in humans. There exists a need 
for new prototypes and new templates for use in the 
design of potential chemotherapeutic agents. Natural 
products are capable of providing such templates. Some 
of the well-recognized anticancer plants are listed in 
Table 1. Further study is required to determine the 
efficacy of these plant products in treating cancers in 
humans (Baldi et al., 2007; Desai et al., 2011). 
 
BREAST CANCER MENACE  
 
Breast cancer is the term used to describe the 
uncontrolled growth of abnormal cells in the breast tissue, 
most commonly in the lobules (milk producing glands) 
and ducts (the passages that carry milk to the nipples), 
leading to the formation of a solid lump or tumour. Breast 
cancer is a systemic disease in that cancer cells may 
start to be disseminated into blood and lymphatic 
systems even in early stages or when the tumor size is 
still small. Active angiogenesis may occur in breast tumor 
nodules as small as 2 mm in diameter. Cancers 
originating from ducts are known as ductal carcinomas 
and those originating from lobules are known as lobular 
carcinomas (Hayat, 2008; Ingelheim, 2011). 
Breast cancer (BC) constitutes a major public health 
issue globally with over 1 million new cases diagnosed 
annually, resulting in over 400,000 annual deaths and 
about 4.4 million women living with the disease. BC 
remains the most feared disease of all women worldwide. 
The causes of breast cancer remain a mystery, with a 
few exceptions. About 70% of women diagnosed with 
breast cancer have no known risk factors. This implies 
that   there  are   risk  factors  that   have   not   yet   been  
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identified. Doctors are beginning to identify lifestyle 
choices that can influence our cancer risk. These lifestyle 
choices include diet, exercise, smoking, alcohol, and 
many other factors (Tabor, 2009). BC affects 12.5% of 
women during their lives. In Nigeria, BC and hypertension 
are two of the commonest degenerative diseases 
responsible for about 16% of all cancer related deaths. 
Out of 89,000 cancer deaths in 2005; 54,000 of these 
were younger than 70 years (Gunduz and Gunduz, 2011; 
Omolara, 2011). BC accounts for 12.5% of deaths 
worldwide, more than HIV/AIDS, tuberculosis and malaria 
deaths combined. Estimated 207,090 women were 
diagnosed with and 39,840 women died of BC in 2010. 
By 2020, 15 million new BC cases are expected yearly, 
and 70% of new BC cases (~10.5 million) will occur in 
developing countries. A total of 1 million BC cases is 
expected yearly in African countries by 2020 with 
500,000 cases expected in Nigeria alone. Late 
presentation of patients at advanced stages when little or 
no benefit can be derived from any form of therapy is the 
hallmark of BC and other cancers among African adults 
resulting in ineffective treatment. 5-year cancer survival 
rate is 10% for Africa against 70% in developed 
countries. In Nigeria alone, average life expectancy for 
women is 48 years and death rate is 16.31/1,000 
deaths (6th highest in the world). Strong dependence on 
traditional medicine is partly due to ethics but mainly due 
to poverty (70% of population live below poverty 
guidelines) (Okobia et al., 2006; Courage-to-dare-
foundation, 2012). In Okobia et al.‘s (2006) study of one 
thousand community-dwelling women from a semi-urban 
neighborhood in Nigeria recruited in January and 
February 2000 using interviewer-administered 
questionnaires designed to elicit sociodemographic 
information and knowledge, attitude and practices of 
these women towards breast cancer, results showed that 
study participants had poor knowledge of breast cancer. 
Mean knowledge score was 42.3% and only 214 
participants (21.4%) knew that breast cancer presents 
commonly as a painless breast lump. Practice of breast 
self-examination (BSE) was low; only 432 participants 
(43.2%) admitted to carrying out the procedure in the 
past year. Only 91 study participants (9.1%) had clinical 
breast examination (CBE) in the past year. Women with 
higher level of education (X2 = 80.66, p < 0.0001) and 
those employed in professional jobs (X2 = 47.11, p < 
0.0001) were significantly more knowledgeable about 
breast cancer. Participants with higher level of education 
were 3.6 times more likely to practice BSE (Odds ratio 
[OR] = 3.56, 95% Confidence interval [CI] 2.58-4.92) 
(Okobia et al., 2006). 
 
Epidemiology of BC in Nigeria 
 
- Lifetime risk for all women for developing this cancer is 
10%. 
- Annual   number   of  new  cases  is  33.6  out  of  every  
Omogbadegun          140 
 
 
 
Table 1. The anticancer plants and their active constituents (Baldi et al., 2007). 
 
Plant  Family  Active constituent(s) 
Acer negundo  Aceraceae  Acer saponin P (Saponin) 
Acnistus arborescens  Solanaceae  Withalerin A (Withanolide) 
Acronychia baueri  Rutaceae  Acronycine (Acrlaone alkaloid) 
Allamanda cathartica  Apocynaceae  Allarnandin (Monoterpene) 
Baccharis megapotamica  Asteraceae  Baccharin (Sesquiterpene) 
Baileya multiradiata  Asteraceae  Pseudoguaianolide 
Bersama abyssinica  Melianthaceae  Hellebrigenin acetate (Buladienullde) 
Bouvardia temifolia  Rubiaceae  Bourvardin (Peptide) 
Brucea antidysenterica  Simaroubaceae  Broceanlin (Simaroubolide) 
Caesalpinia gilliesii  Fabaceae  Cesalin 
Camptotheca acuminata  Nyssaceae  Camptothecin (Pyrraloquinolille alkaloid) 
Catharanthus roseus  Apocynaceae  Vinblastine, Vincristine (Bis-indole alkaloid) 
Cephalis acuminata  Rubiaceae  Emetine (Isoquinoline alkaloid) 
C. ipeccacuanha  Rubiaceae  Emetine (Isoquinoline alkaloid) 
Cephalotaxus harringtonia  Cephalotaxaceae  Harringtonine (Cephalotaxine alkaloid) 
Cocculus sp.  Menispennaceae  Gocculine, Cocculidine (Bisclaurine alkaloid) 
Colchicum autumnale  Liliaceae  Colchicine (alkaloid) 
C. speciosum  Liliaceae  Colchicine (alkaloid) 
Crocosmia crocosmiiflora  Iridaceae  Medicagenic acid (Saponin) 
Crotalaria assamica  Leguminosae  Monocrotaline (Pyrrolizidine alkaloid) 
C. spectabilis  Leguminosae  Monocrotaline (Pyrrolizidine alkaloid) 
Croton macrostachys  Euphorbiaceae  Crotepoxide 
C. tiglium  Euphorbiaceae  Phorbol derivatives (Terpenoid) 
Cyclea peltata  Menisperrnaceae  Tetrandrine (Isoquinoline alkaloid) 
Daphne mezereum  Thymelaeaccae  Mezerein (Diterpene) 
Elephantopus elatus  Asteraceae  Elephantopin (Sesquiterpene) 
E. mollis Asteraceae  Molephantinin  (Sesquiterpene) 
Eupatorium hyssopifolium  Asteraceae  Eupahyssopin (Sesquiterpene) 
Euphorbia escula  Euphorbiaceae  Ingenal dibenzoate 
Fagara macrophylla  Rutaceae  Nilidine (Benzophenanthridine alkaloid) 
F. zanthoxyloides  Rutaceae  Fagaronine (Benzophenanthridine alkaloid) 
Gnidia lamprantha  Thymelaceaceae  Guidin (Diterpene) 
Gossypium sp.  Malvaccae  Gossypol (Sesquiterpene dimer) 
Helenium autumnale  Asteraceae  Helevalin (Sesquiterpene) 
H. microcephaiam  Asteraceae  Microlenin (Sesquiterpene dimer) 
Heliotropium indicum  Boraginaceae  Indicine-N-oxide (Pyrrolizidine alkaloid) 
Holacantha emoryi  Simaroubaceae  Holacanthone (Sirnaroubalide) 
Hymenoclea salsola  Asteraceae  Ambrosin (Sesquiterpene) 
Ipomoea batatas C onvovulaceae  4-Ipomeanal (Monoterpene) 
Jacaranda caucana  Bignoniaceae  Jacaranone (Quinone) 
Jatropha gossypiifolia  Euphorbiaceae  Jatrophone (Diterpene) 
Juniperus chinensis  Cupressaceae  Podophyllotoxin (Lignan) 
Liatris chapmanii  Asteraceae  Liatrin (Sesquiterpene) 
Linum album  Linaceae  Podophyllotoxin (Lignan) 
Linum flavum  Linaceae  5-Methoxypodophyllotoxin (Lignan) 
Mappia foetida  Olinaceae  Camptothecin (Pyrroloquinoline alkaloid) 
Marah omganus  Cucurbitaceae  Cucurbitacin E 
Maytenus buchananii  Celaslraceae  Maytansine (Ansa macrolide) 
M. ovatus  Celastraceae  Maytansine (Ansa macrolide) 
M. serrata  Celastraceae  Maytansine (Ansa macrolide) 
Montezuma speciasissima  Malvaceae  Gossypol (Sesquiterpene dimer) 
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Table 1. Contd. 
 
Ochrosia elliptica  Apocynaceae  Ellipticine (Pyridocarbazole alkaloid) 
O. maculata  Apocynaceae  9-Methoxyellipticine (Pyridocarbazole alkaloid) 
O. moorei  Apocynaceae  Ellipticine (Pyridocarbazole alkaloid) 
Parquetina nigrescens  Asclepiadaceae Strophanthidin (Cardenolide) 
Penstemon deutus  Scrophulariaceae  Penstimide (Monoterpene) 
Phyllanthus acuminatus  Euphorbiaceae  Phyllathoside 
Pierreodendron kerstingii  Sapotaceae  Glaucarbuinone (Simaroubolide) 
Piper futokadzura  Piperaceae  Crotepoxide 
Podtxatpus gracilori  Podocarpaceae  Podolide (Dilactone) 
Podophyllum hexandrum  Podophyllaceae  Podophyllotoxin, Peltatin (Lignan) 
P. peltatum  Podophyllaceae  Podophyllotoxin, (Lignan) 
Putterlickia verrucosa  Celastraceae  Maytansine (Ansa macrolide) 
Simarouba glauka  Simaroubaceae  Glaucarubinone (Simaroubolide) 
Steganotaenia araliaceae  Umbelliferae  Liatrin (Sesquiterpene) 
Stereospermum suaveolens  Bignoniaceae  Lapachol (Quinone) 
Strophanthus sp.  Apocynaceae  Strophanthidin (Cardenolide) 
Taxodium distichum  Taxodiaceae  Taxodione (Diterpene) 
Taxus baccata  Taxaceae  Paclitaxel (Diterpene) 
T. brevifolia  Taxaceae  Paclitaxel (Diterpene) 
Thalictrum dasycatpum  Ranunculaceae  Thalicarpine (Isoquinoline alkaloid) 
T. minus  Ranunculaceae  Thalicarpine (Isoquinoline alkaloid) 
Tripterygium wilfordii  Celastraceae  Tripdiolide, Triptolide (Diterpene) 
Tylophora asthmatica  Asclepiadaceae  Tylophorine 
T. cerbiflora  Asclepiadaceae  Tylocrebine (Phenanthroidolizidine alkaloid)  
Vernonia guineensis  Asteraceae  Vemolepin (Sequiterpene lactone) 
V. hymenolepis  Asteraceae  Vemolepin (Sequiterpene lactone) 
Withania somnifera  Solanaceae  Withaferin A, B (Withanolides) 
Zaulzainia sp.  Rubiaceae  Zaluzonic C (Ridoid) 
Zanthoxylum sp.  Rutaceae  Nitidine (Benzoohenathridine) 
 
 
 
100,000 women. 
- Affects at least 116 out of every 100,000 women yearly. 
- 500,000 new diagnoses would be made here by the end 
of 2010. 
- 15% of the cases occur in women under 30 years. 
- Most women present in advanced stages. 
- With late presentation, many die within a short period. 
 
Causes of BC 
 
Risk factors include: 
 
- Age: occurrence increases with age (peak is 35-50 
years). 
- Starting menstruation early, that is, before the age of 10 
years. 
- Reaching menopause late, that is, after the age of 55 
years. 
- Having one first child late, that is, after the age of 30 
years. 
- Breast feeding for very short periods. 
- Having close family members who have had BC. 
- Genetics‘ predispositions. 
- Never had any children. 
- Female with less than 3 pregnancies (LASG-MOH, 
2009). 
 
Figure 1 summarizes the unavoidable (inherited) and 
modifiable risk factors that can ultimately lead to 
tumorigenesis. Genes/pathways/risk factors are shown in 
red; inherited or unmodifiable factors are shown in green; 
modifiable variables are shown in blue; life events are 
represented by gray boxes; increased/positive effects are 
denoted by solid arrows; and reduced/negative effects 
are denoted by dashed arrows; AIs, aromatase inhibitors; 
ATM, ataxia telangiectasia mutated; BRCA1 and BRCA2 
(genes in which deleterious germline mutations increase 
the risk of cancer); CAFs, cancer-associated fibroblasts; 
CHEK2, CHK2, checkpoint homolog; HRT, hormone 
replacement therapy; and SERMs, selective estrogen 
receptor modulators (Howell et al., 2005). BRCA1 and 
BRCA2 are tumor suppressor genes that are  involved  in  
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(Howell et al. 2005). BRCA1 and BRCA2 are tumor suppressor genes that are 
involved in multiple cellular processes including DNA repair and transcriptional 
regulation in response to DNA damage, chromosomal stability and cell-cycle 
regulation (Bafford et al. 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Overview  
INFLAMMATION 
Early menarche 
TUMORIGENESIS DENSITY 
RE-EXPRESSION OF 
FETAL GENES 
RADIOSENSITIVITY 
Aging 
GENOMIC INSTABILITY 
ESTROGEN 
OBESITY 
No or late 1st 
pregnancy 
Late menopause 
HRT Oophprectomy SERMs & AIs Exercise Alcohol Healthy diet 
Genes/ pathways/ risk factors 
Life events 
 Modifiable variables 
Modifiable 
risk factors/ 
management 
Steroid hormone 
pathway 
Obesity genes 
BRCA1/BRCA2 
CHEK2/ATM 
HIGH PENETRANCE GENES     
Unavoidable 
(inherited) 
risk factors 
LOW PENETRANCE GENES       
 
 
 
Figure 1. Overview of risk factors associated with breast cancer (Howell et al., 2005). 
 
  
 
multiple cellular processes including DNA repair and 
transcriptional regulation in response to DNA damage, 
chromosomal stability and cell-cycle regulation (Bafford 
et al., 2008). 
Over the course of the last decade, the treatment of 
breast cancer has evolved quite rapidly. New scientific 
and clinical advances have modified the standard of care 
and led to improved patient outcomes. At the same time, 
the treatment of breast cancer has become increasingly 
complex, requiring the comprehensive review and 
assessment of multiple issues, genetics, radiology, 
surgery, reconstruction, fertility radiation, chemotherapy, 
and more. As a result, the harmony and open 
communication between these specialties facilitated by a 
multidisciplinary team approach are crucial in providing 
the  best   care   to   patients   and   ensuring   successful 
treatment (Taghian et al., 2009). 
 
Complementary therapies 
 
Complementary therapies are increasingly sought by 
cancer patients to control treatment-related symptoms. 
Unproven methods that do not actually treat cancer are 
often promoted falsely as cancer cures. These are 
termed ―alternative therapies.‖ Typically expensive and 
potentially harmful, they can interact with chemotherapy 
drugs and other medication. Complementary therapies 
such as music, massage, acupuncture and meditation 
are noninvasive, gentle techniques applied to control 
physical and emotional symptoms commonly 
experienced by cancer patients. Plants are the most 
exclusive source of drugs for the  majority  of  the  world‘s  
 
 
 
 
Table 2. Concentrations of antitumor compounds present in higher 
plants (Baldi et al., 2007). 
 
No.  Antitumor compound  Concn. [dry wt. %] 
1 Baccharin  2.0×10–2 
2  Bruceantin  1.0×10–2 
3 Camptothecin  5.0×10–3 
4 Ellipticine  3.2×10–5 
5 Homoharringtonine  1.8×10–5 
6 Maytansine  2.0×10–5 
7 Podophyllotoxin  6.4×10–1 
8 Taxol  5.0×10–1 
9 Tripdiolide  1.0×10–3 
10 Vinblastine, Vincristine  5.0×10–3 
 
 
 
population, and plant products constitute about 25% of 
prescribed medicines. The impact of natural products 
upon anticancer drug discovery and design can be 
gauged by the fact that approximately 60% of all drugs, 
now in clinical trials for the treatment of cancer, are either 
natural products, compounds derived from natural 
products, or contain pharmacophores derived from 
natural products. These therapies are used as adjuncts to 
mainstream cancer treatment. Some important antitumor 
compounds isolated from different parts of higher plants 
are listed in Table 2. Patients and physicians should be 
aware of the distinction between questionable methods 
that are not helpful, and complementary therapies that 
successfully reduce symptoms and enhance quality of 
life. Easy access to information and misinformation about 
these therapies via the Internet and print media 
compounds this problem (Baldi et al., 2007; Cassileth et 
al., 2007). 
As shown in Table 3, biologically-based practices were 
noted as the types of CAM most used by women with 
breast cancer, followed by mind-body medicine, whole 
medical systems, and energy medicine. Sources of 
information about CAM use for women with breast cancer 
vary widely, including family, friends, mass media, 
healthcare providers, CAM providers, and self-help 
groups. Sociodemographic factors that appear to be 
related to CAM use were younger age, higher education, 
higher income, married status, involvement in a support 
group, and health insurance. The reasons for CAM use 
reported by women with breast cancer were to help 
healing, to promote emotional health, and to cure cancer. 
Oncology nurses should obtain detailed information about 
CAM use by their patients and explore why women with 
breast cancer do not discuss the use of CAM with 
healthcare providers (Wanchai et al., 2010). 
 
Diagnosis and treatment 
 
One of the main causes of failure in the treatment of 
breast cancer is the intrinsic presence of, or development  
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of, drug resistance by the cancer cells. Recent studies on 
the mechanisms of cancer drug resistance have yielded 
important information highlighting both how tumour cells 
may escape these therapeutic constraints and how drug 
resistance may further impinge on tumour cell functions 
that may ultimately promote an adverse cell phenotype. 
New targets have been identified with potential 
therapeutic applications in resistant breast cancer leading 
to the subsequent evaluation of inhibitors of these targets 
in preclinical studies. Importantly, there is increasing 
evidence from such studies demonstrating the benefit of 
novel combination strategies as potential avenues for 
future drug regimens (Hiscox et al., 2009). 
Cancer can be treated in a number of ways: 
 
(i) By surgery, to remove the tumor, sometimes with 
surrounding tissue and local lymph nodes. Surgery can 
also be done to remove part of a tumor or to relieve 
symptoms caused by the tumor. 
(ii) By chemotherapy, treatment with drugs that destroy 
cancer cells or stop them from growing. 
(iii) By biologic therapy, treatment with immune 
substances that destroy cancer cells or strengthen the 
ability of the immune system to destroy cancer cells. 
(iv) By hormonal therapy, treatment that alters specific 
hormone levels in the body by stopping the production of 
the hormone, blocking the hormone, or adding hormone, 
thereby slowing or stopping the growth of cancer cells. 
(v) By radiation therapy, the use of high-energy radiation 
to destroy cancer cells. 
 
The mode of action of some promising chemo-
therapeutics from natural origin and their derivatives is 
indicated in Table 4 (Baldi et al., 2007). 
Surgery and radiation therapy are local treatments, 
directed to a particular part of the body. Chemotherapy, 
biologic therapy, and hormonal therapy are systemic 
treatments, which travel through the bloodstream to all 
parts of the body. Cancer treatments are constantly 
evolving as doctors better understand the biology of how 
cancers start and grow and as they develop new ways to 
perform less invasive surgery and to more precisely 
deliver radiation therapy. For many cancers, doctors use 
combined modality therapy, that is, a combination of 
treatments. Oncologists, doctors who specialize in the 
treatment of cancer, can recommend the type of 
treatment that is best for you. The treatment depends on 
the type of cancer, the stage of disease, and your general 
state of health. Depending on your situation, the goal of 
the treatment may be to cure the disease, to control the 
growth of the cancer, or to relieve symptoms and improve 
quality of life (that is, palliation) (Hiscox et al., 2009). 
Surgery, radiation treatment, and new advanced 
therapies available in the developed world contribute to 
good prognosis. 
Nigeria remains ill-equipped to deal with the 
complexities of BC. Public health messaging is scheduled  
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Table 3. Complementary and Alternative Medicine use among women with breast cancer (Wanchai et al., 2010). 
 
Study Sample Method Types of CAM used 
Sources of 
CAM 
Information 
Sociodemographic  
Factors Related to 
CAM Use 
Reasons for 
CAM Use 
Abdullah 
et al., 
2003 
352 patients with 
breast cancer in 
Hong Kong, 
China 
Self-
administered 
questionnaires  
Lingzhi (45%), shark 
cartilage (44%), fungi 
(29%), ginseng (14%), Qi 
gong (14%), and others 
such as herbs and 
vegetables, natural therapy, 
animal or animal extracts, 
or Chinese medical 
practitioners (35%)  
Friends, family 
members or 
relatives, mass 
media, self-help 
groups, posters, 
brochures, and 
pamphlets 
Younger age and 
higher education 
Many believed 
CAM could 
serve as a 
supplement to 
orthodox 
treatment. 
       
Alferi et 
al., 2001 
231 African 
American, 
Hispanic 
American, and 
Caucasian 
women with 
early-stage 
breast cancer 
Self-
administered 
questionnaires  
Meditation or imagery 
(29%), support groups 
(23%), psychotherapy 
(22%), spiritual healing 
(21%), herbal medications 
(14%), massage or body 
therapy (11%), and 
acupuncture (1%) 
Not specified Younger age and 
higher education 
Not specified 
       
Ashikaga 
et al., 
2002 
148 patients with 
breast cancer in 
Vermont 
Face-to-face 
interviews 
Vitamins (63%), herbal 
treatments (21%), medi-
tation (21%), traditional 
massage (20%), yoga 
(12%), chiropractic (7%), 
homeopathy (7%), 
naturopathy (5%), 
acupuncture (5%), hypnosis 
(3%), and other (16%) 
Not specified Higher education, 
higher income, and 
younger age 
Patients 
believed that 
CAM was 
helpful to 
recovery. 
       
Balneav
es et al., 
1999 
52 women with 
all stages of 
breast cancer in 
an urban center 
in central 
Canada 
Face-to-face 
interviews 
Meditation or relaxation 
(64%), vitamins or tonics 
(58%), spiritual or faith 
healing (54%), herbal 
remedies (50%), special 
food or diets (27%), im-
mune therapies (23%), 
massage (19%), detoxifi-
cation (17%), and shark 
cartilage (8%) 
Not specified Higher education Patients 
believed that 
CAM assisted 
the body‘s 
natural ability 
to heal. 
       
Balneav
es et al., 
2006 
334 patients with 
breast cancer 
from central 
Canada who 
were chosen 
from a cancer 
registry 
Self-
administered 
questionnaires  
Vitamin or mineral 
supplements (68%), herbal 
or plant (42%), spiritual 
therapies (35%), physical or 
movement therapies (32%), 
psychological or expressive 
therapies (24%), alternative 
medical systems (17%), 
energy therapies (16%), 
pharmacologic or biologic 
supplements (15%), diet 
therapies (10%), and others 
(3%) 
Not specified Higher education 
and younger age 
Not specified 
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Burstein 
et al., 
1999 
480 women with 
early-stage 
breast cancer in 
Massachusetts 
Telephone 
interviews 
Psychological therapies 
such as relaxation, spiritual 
healing, and imagery (29%) 
and healing therapies such 
as megavitamin, herbs, 
massage, and acupuncture 
(28%) 
Not specified Higher education 
and younger age 
Not specified 
       
Chen et 
al., 2008 
5,046 women 
with primary 
breast cancer in 
Shanghai, China 
Face-to-face 
interviews 
Supplements such as 
sporophyte, vitamins, fish 
oil, or ginseng (77%) and 
traditional Chinese 
medicine such as herbal 
medicine and acupuncture 
(71%) 
Not specified Higher education, 
higher income, being 
married, and 
younger age 
To treat 
cancer, boost 
the immune 
system, and 
decrease 
menopausal 
symptoms 
       
Chou et 
al., 2000 
45 patients with 
breast cancer 
being treated at 
the University of 
California, Los 
Angeles, 
Medical Center 
Face-to-face 
interviews 
Vitamins, dietary changes, 
herbs, and spiritual healing 
Family, friends, 
and media 
Being married and 
younger age 
To improve 
health, follow 
the physician‘s 
recommendatio
ns for vitamin 
intake, and 
decrease side 
effects of 
adjuvant treat-
ments 
       
Crocetti 
et al., 
1998 
242 patients with 
breast cancer in 
Italy 
Self-
administered 
questionnaires  
Homeopathy, manual 
healing, herbs, and acu-
puncture 
Not specified Higher education 
and younger age 
Physical 
distress 
       
Cui et 
al., 2004 
1,065 patients 
with breast 
cancer in 
Shanghai, China 
Face-to-face 
interviews 
Traditional Chinese 
medicine (87%); Chinese 
herb medicine (86%); 
supplements (85%); physi-
cal exercises such as Qi 
gong, tai chi, and gong fu 
(66%); support groups 
(17%); and acupuncture 
(5%) 
Not specified Higher education, 
having a younger 
age, being married, 
and higher income 
Patients 
believed it 
would treat 
their cancer, 
enhance their 
immune 
system, 
prevent 
metastasis or 
manage other 
discomforts, 
and lessen 
menopausal 
symptoms. 
       
Fasching 
et al., 
2007 
796 patients with 
breast cancer 
and 234 patients 
with gynecologic 
cancer in 
Duesseldorf, 
Germany 
Face-to-face 
interviews 
Dietary supplements (77%), 
mistletoe therapy (74%), 
enzymatic therapy (59%), 
immunoaugmentative 
therapy (55%), physical 
therapy (51%), traditional 
Chinese medicine (43%), 
biologic treatment (29%), 
cancer diets (20%), and 
psychological therapy 
(20%) 
Physician, 
friends, family 
members, and a 
health 
insurance 
company 
Not specified Not specified 
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Gulluogl
u et al., 
2008 
129 patients with 
breast cancer in 
North-Western 
Turkey 
Self-
administered 
questionnaires  
Herbal medicine (67%) 
spiritual healing (24%), 
nutritional support (22%), 
dietary regulation (11%), 
physical exercise (11%), 
musical therapy (4%), 
massage (2%), acupuncture 
(2%), and meditation (2%) 
Friends and 
relatives 
Younger age and 
being married 
To improve 
health status 
       
Hann et 
al., 2006 
166 women 
diagnosed with 
early-stage 
breast cancer in 
the North-
Eastern United 
States 
Telephone 
interviews 
Dietary (54%), vitamins 
(44%), herbal methods 
(44%), physical method 
such as massage or acu-
puncture (44%), meditation 
(11%), and prayer (6%) 
Not specified Younger age, higher 
education, higher in-
come, and 
attendance in a 
support group 
Not specified 
       
Helyer et 
al., 2006 
32 women with 
locally advanced 
breast cancer in 
Toronto, Canada 
Self-
administered 
questionnaires  
Dietary such as vitamins, 
minerals, and vegetarian or 
low-fat diets; herbal or 
homeopathy; psychological 
methods such as 
meditation, imagery, 
hypnosis, or faith; physical 
methods such as massage, 
acupuncture, yoga, or tai 
chi; and alternative 
providers such as 
chiropractor, naturopathic 
doctor, acupuncturist, or 
traditional Chinese 
medicine doctor 
Not specified Younger age, higher 
income, being 
married, Asian 
ethnicity, having 
private health insur-
ance, and 
involvement in 
cancer support 
groups 
Patients 
believed that 
CAM would 
assist body 
healing, boost 
the immune 
system, and 
give them a 
feeling of 
control. 
 
       
Henders
on & 
Dona-
telle, 
2003 
551 women 
diagnosed with 
breast cancer in 
Portland, OR 
Telephone 
interviews 
Relaxation or meditation 
(28%), herbs (26%), 
spiritual healing (26%), 
megavitamins or nutrient 
therapies (23%), massage 
(19%), imagery (13%), 
chiropractor (13%), 
naturopathy (13%), support 
groups (13%), lifestyle and 
diet (9%), immune therapy 
(5%), acupuncture (5%), 
energy healing (2%), 
biofeedback (2%), and 
hypnosis (1%) 
Not specified Higher education, 
younger age, and 
having private health 
insurance  
To enhance 
overall quality 
of life, give 
feelings of 
control, 
strengthen the 
immune 
system, and 
reduce stress 
       
Kremser 
et al., 
2008 
367 patients with 
breast cancer in 
Australia 
Self-
administered 
questionnaires  
Vitamin supplements (54%), 
support groups (50%), 
massage (41%), meditation 
(39%), diets (24%), yoga 
(22%), herbal remedies 
(19%), juices (16%), Reiki 
(15%), acupuncture (14%), 
exercise (10%), reflexology 
(8%), homeopathy (8%), art 
therapy (5%), tai chi (5%), 
Chinese medicine (5%), 
dragon boating (5%), bach 
Media such as 
Internet, 
magazines, 
newspapers, 
television, and 
radio; doctor; 
friends; other 
patients; family; 
support groups; 
naturopath 
practitioner; 
nurse; Chinese 
Higher education 
and younger age 
Patients 
believed CAM 
improved their 
physical and 
emotional well-
being, boosted 
the immune 
system, 
reduced side 
effects of 
treatment, 
prevented the 
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   flowers (4%), naturopathy 
(4%), and shark cartilage 
(4%) 
medicine 
practitioner; 
pharmacist; and 
homeopath 
 recurrence of 
cancer, treated 
cancer, and 
reduced 
symptoms 
associated with 
breast cancer. 
       
Lee et 
al., 2000 
379 women with 
breast cancer in 
San Francisco, 
CA 
Telephone 
interviews 
Mental methods (30%), 
dietary therapies (27%), 
physical methods (14%), 
herbal or homeopathy 
(14%), and others (1%) 
Not specified Younger age, higher 
education, having 
private insurance, 
higher income, and 
use of support 
groups  
Not specified 
       
Lengach
er et al., 
2006 
105 patients with 
breast cancer in 
Florida 
Self-
administered 
questionnaires  
Diet and nutritional 
supplements such as vita-
mins or minerals, 
macrobiotics, herbs, and 
antioxidants (68%); stress-
reducing techniques such 
as art therapy, music 
therapy, humor, imagery, 
prayer or spiritual healing, 
yoga, or meditation (66%); 
and traditional and ethnic 
medicines such as 
massage, chiropractic, 
reflexology, therapeutic 
touch, and aromatherapy 
(11%) 
Not specified Higher education Patients 
believed that 
CAM reduced 
physical 
symptoms or 
side effects, 
reduced 
psychological 
stress, 
addressed their 
dissatisfaction 
with traditional 
medical care, 
and helped 
them gain a 
sense of 
control.  
       
Molassio
tis et al., 
2006 
282 patients with 
breast cancer 
from 11 
countries in 
Europe 
Self-
administered 
questionnaires  
Herbal medicine (46%), 
spiritual therapies (21%), 
relaxation (21%), teas 
(20%), homeopathy (19%), 
vitamins or minerals (15%), 
massage (15%), 
visualization (10%), 
acupuncture (10%), animal 
extracts (9%), and support 
groups 8%) 
Friends, family, 
media, CAM 
practitioners, 
Internet, nurses, 
physicians, and 
religious groups 
Higher education 
and younger age  
To fight cancer, 
improve 
physical and 
emotional well-
being, increase 
hope and 
optimism, and 
counter ill 
effects 
       
Montaze
ri et al., 
2005 
177 patients with 
breast cancer in 
Iran 
Self-
administered 
questionnaires  
Prayer or spiritual healing 
(74%), bio energy (12%), 
homeopathy (3%), herbs 
(3%), acupuncture (2%), 
meditation (2%), yoga (2%), 
sports medicine (2%), and 
counseling (2%) 
Not specified No significant factors 
were found. 
Not specified 
       
Morris et 
al., 2000 
288 patients with 
breast cancer 
and 329 patients 
with other forms 
of cancer from a 
tumor registry in 
the United 
States 
Self-
administered 
questionnaires  
Nutrition (65%), massage 
(57%), herbs (49%), 
chiropractor (43%), 
relaxation (41%), and acu-
puncture (31%) 
Not specified Not specified To relieve pain, 
control side 
effects, boost 
the immune 
system, and 
cure cancer 
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Moschèn 
et al., 
2001 
117 patients with 
breast cancer in 
Australia 
Self-
administered 
questionnaires  
Vegetable drinks (53%), 
megavitamins (51%), 
mistletoe (49%), minerals 
(48%), special diets (36%), 
homeopathy (31%), special 
teas (29%), relaxation 
training (26%), enzyme 
(20%) and thymus 
preparations (15%), and 
other (29%)  
Physicians, 
friends and 
other patients, 
magazines or 
books, and 
general practi-
tioners 
Higher education, 
younger age, more 
active style of 
coping, and greater 
religious 
involvement 
Patients sought 
an active role 
in their 
treatment, had 
a wish to leave 
nothing untried, 
felt CAM 
complemented 
conventional 
treatment, and 
believed CAM 
was a gentle 
treatment free 
from adverse 
effects. 
       
Navo et 
al., 2004 
250 patients with 
breast cancer 
and 250 patients 
with gynecologic 
cancer in Texas 
Face-to-face 
interviews 
Megavitamins or minerals 
(59%) and herbals such as 
glucosamine chondroitin, 
garlic, CQ 10, green tea, 
flaxseed, and fish oil (47%) 
Media, friends 
and family, 
health profes-
sionals, 
alternative care 
specialists, and 
formal 
education 
Older age and 
higher education 
To improve 
overall health, 
reduce adverse 
drug reactions, 
improve quality 
of life, and treat 
cancer 
       
Owens et 
al., 2009 
125 Hispanic 
patients with 
cancer in Texas 
Self-
administered 
questionnaires  
Prayer (93%), humor (83%), 
music (70%), exercise 
(65%), relaxation therapy 
(44%), spirituality (40%), 
imagery (32%), massage 
(27%), herbs (26%), folk 
therapy (22%), group 
therapy (17%), diet (16%), 
energy therapy (11%), yoga 
(11%), biotherapy (10%), 
homeopathy (7%), 
chiropractor (6%), Reiki 
(5%), acupuncture (4%), 
and hypnosis (2%) 
Not specified Higher income Not specified 
       
Patterson 
et al., 
2002 
126 patients with 
breast cancer, 
114 with 
prostate cancer, 
and 116 with 
colorectal 
cancer in Wash-
ington 
Telephone 
interviews 
Dietary supplements (65%); 
mental therapies such as 
meditation, spiritual 
activities, and prayer (19%); 
and alternative providers 
such as naturopathic 
physicians, massage 
therapists, and spiritual 
advisors (17%) 
Not specified Higher education Patients used 
CAM for 
general health 
and well-being, 
to treat their 
cancer, to ease 
cancer-related 
symptoms, and 
to treat other 
diseases. 
       
Rakovitch  
et al., 
2005 
251 women 
diagnosed with 
breast cancer in 
Toronto, Canada 
Self-
administered 
questionnaires 
Dietary methods such as 
vitamins and low-fat 
vegetarian diets (91%), 
psychological methods such 
as meditation and relaxation 
(54%), physical therapies 
such as massage (39%), 
and herbal or homeopathy 
(31%) 
Not specified Higher education, 
younger age, having 
private health insur-
ance, and having 
full-time employment 
To cure 
cancer, prevent 
the spread and 
recurrence of 
cancer, assist 
other treat-
ments, relieve 
symptoms, 
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      boost the im-
mune system, 
increase 
quality of life, 
and give a 
feeling of 
control 
       
Rees et 
al., 2000 
714 women with 
breast cancer in 
South Thames, 
United Kingdom 
Self-
administered 
questionnaires  
Massage or aromatherapy 
(14%); psychotherapy 
(13%); chiropractic or 
osteopathy (10%); relax-
ation, yoga, and meditation 
(8%); healing (8%); 
reflexology (7%); 
homeopathy (6%); 
acupuncture (5%); herbal 
medicine (3%); nutrition 
(3%); hypnotherapy (2%); 
and use of support groups 
(1%)  
Not specified Higher education, 
younger age, and 
previous CAM use  
To cure or slow 
down cancer 
and relieve 
symptoms 
       
Richardso
n et al., 
2000 
60 patients with 
breast cancer 
and 393 patients 
with other forms 
of cancer in 
Texas 
Self-
administered 
questionnaires  
Spiritual practices (81%), 
vitamins or herbs (63%), 
movement or physical 
therapies (59%), mind or 
body (49%), psychotherapy 
(41%), special diet (32%), 
and other (11%) 
Not specified Younger age Patients felt 
hopeful when 
using CAM, 
believed it to 
be nontoxic, 
and felt that 
CAM use 
addressed their 
need for more 
control. 
       
Salmen-
pera, 
2002 
216 patients with 
breast cancer 
and 190 patients 
with prostate 
cancer in South-
Western Finland 
Self-
administered 
questionnaires  
Vitamins, trace elements, or 
antioxidant treatments; 
dietary supplements and 
natural products; spiritual 
healing; homeopathy and 
extract of mistletoe; and 
other types such as 
aromatherapy and 
reflexology 
Family or 
friends, reading, 
and healthcare 
professionals 
Higher education 
and younger age 
Patients 
believed they 
were doing as 
much as they 
could do; CAM 
gave them 
hope and 
addressed their 
disappointment 
in conventional 
treatments.  
       
Shen et 
al., 2002 
115 patients with 
advanced-stage 
breast cancer in 
an urban center 
in the United 
States 
Face-to-face 
structured 
interviews 
Herbal medicine, tai chi, 
yoga, Qi gong, imagery, 
spiritual healing, massage, 
megavitamin, shark 
cartilage, special diets, 
energy healing, acupunc-
ture, hypnosis, chiropractic, 
biofeedback, homeopathy, 
and folk remedies 
Friends, family 
members, mass 
media, 
healthcare 
professionals, 
and CAM 
practitioners 
Higher education To boost the 
immune 
system, treat 
cancer, relieve 
side effects of 
treatment, 
relieve 
symptoms, 
reduce stress, 
and trigger 
detoxification 
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Vande-
Greek et 
al., 1999 
112 women with 
early-stage 
breast cancer in 
the United 
States 
Face-to-face 
interviews 
Prayer (76%), exercise 
(38%), spiritual healing 
(29%), megavitamins 
(25%), relaxation (21%), 
self-help groups (21%), 
imagery (19%), herbs 
(14%), and massage (10%) 
Internet Not specified Influence from 
family folklore  
       
Van der 
Weg & 
Streuli, 
2003 
53 patients with 
breast cancer 
and 55 patients 
with other forms 
of cancer in a 
rural area of 
Switzerland 
Face-to-face 
interviews 
Mistletoe (74%), 
homeopathy (24%), diets 
(12%), bach flower 
remedies (10%), music and 
color therapy (7%), 
massage (7%), spiritual 
healing (7%), metals and 
crystals (7%), hypnosis 
(2%), acupuncture (2%), 
osteopathy (2%), bio-
feedback (2%), and 
Simonton therapy (2%)  
Not specified Not specified Patients 
wanted to do 
as much as 
possible, to 
feel more 
hopeful, and to 
harness their 
mental energy; 
they also 
believed CAM 
was nontoxic, 
corresponded 
well to their 
lifestyles, 
addressed their 
disappointment 
in conventional 
treatment, and 
helped them 
avoid 
chemotherapy 
or 
radiotherapy. 
       
Yap et al., 
2004 
290 women 
diagnosed with 
early-stage 
invasive breast 
cancer in 
Toronto, Canada 
Self-
administered 
questionnaires  
Extracts from organisms 
such as evening primrose 
oil or fish oil (28%), herbal 
therapies (24%), minerals 
(11%), energy life force 
therapies such as 
acupuncture and life path 
(5%), vitamins (3%), 
immune boosters (1%), diet 
therapies (1%), and drugs 
(1%) 
Not specified Younger age Not specified 
 
 
 
to increase, but testing and care facilities are few, 
unevenly distributed, and old. Most of the patients need 
radiation treatment, chemotherapy, and hormonal 
replacement therapy because of heavy disease load on 
the breast and metastasis. Treatment cost is prohibitive 
(Nigeria‘s annual GDP is about 7%). Healthcare spending 
has not been a priority of our government. Surgery for 
advanced BC in Nigeria features mastectomies 
predominance and cases with small volume of breast 
disease (or post neoadjuvant) (LASG-MOH, 2009; 
Ogundiran and Ezeome, 2008; Globalpressinstitute, 
2012). It is complacent to continue subjecting at least 
70%  of  women  with  breast  cancer  to  surgery,  a futile 
mutilating procedure. There is no evidence that early 
mastectomy affects survival; if patients knew this, they 
would most likely refuse surgery. Basically, all types and 
combinations of conventional breast cancer treatment 
appear to result in the same low long-term survival rates 
(Last, 2010). 
 
Treatment cost 
 
In Nigeria, the cost of BC treatment is minimally put at: 
 
(i) Histology - ₦10,000 ($90.00) per month ₦25,000 
($225.00) per week, for 4 weeks. 
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Table 4. Some chemotherapeutic products from natural sources, and their mode of action (Baldi et al., 2007).  
 
Source 
Natural compounds or its 
derivatives 
Mode of action 
Cancer  
inhibited 
Podophyllum 
spp. 
Podophyllotoxin (Natural) 
As a mitotic spindle poison, binds the 
microtubule and causes mitotic arrest in 
Metaphase 
Lung 
   
Etoposide and teniposode 
(Semisynthetic derivatives) 
Induce a premitotic blockage in the cell 
cycle, at two specific places, either in late  
S-phase or in early G-phase, by binding to 
and stabilizing the cleavable complex of 
DNA–topoisomerase II. 
Lung, testicular, 
leukemias 
    
Taxus baccata 
10-Deacetyl  Baccatin 
111:Docetaxel (Semisynthetic 
derivatives) 
Promotes tubulin assembly and inhibition 
of microtubule depolymerization; also acts  
as a mitotic spindle poison  and induced 
mitotic block in  proliferative cells. 
Breast, ovarian, 
nonsmall- cell lung, 
head and neck, 
colorectal melanoma 
    
Taxus brevifolia Paclitaxel (Natural) 
Promotes assembly of microtubules, 
stabilizes them against depolymerization, 
and inhibits cell replication; causes cell 
apoptosis. 
Advanced   breast, 
ovarian, 
adenocarcinoma, and 
other solid tumors 
    
Camptotheca 
acuminata 
10-hydroxy camptothecin, (Natural) 
Irinotecan (CPT-11),  
SN-38  (Semisynthetic derivatives) 
Inhibits action of topoisomerase I, prevents 
religation of DNA strand, results in cell 
death.  
Liver, colorectal, head 
and neck cancer, 
leukemia 
 
 
 
 
(ii) Cytology - ₦5,000 ($45.00). 
(iii) Mammogram - ₦7,000 ($55.00) per session for 
several sessions. 
(iv) Chest x-ray - ₦1,000 ($10.00). 
(v) ECG - ₦750 ($7.50). 
(vi) Radiotherapy - ₦100,000 ($900.00). 
(vii) Chemotherapy - ₦28,000 - ₦35,000 ($228.00 - 
$315.00) (for six sessions with interval of three weeks). 
(viii) Laboratory tests - ₦30,000 ($270.00). 
(ix) Treatment/surgery - ₦150,000 - ₦200,000 ($1,300.00 
- $1,800.00) (depending on the severity/complexity of 
each cancer case) (LASG-MOH, 2009). 
 
Prevalence rates of complementary therapy use by 
women with breast cancer have been estimated to range 
from 31.5 to 73%. The most common complementary 
therapies used by women with breast cancer include 
vitamin/mineral supplements, meditation/relaxation 
therapies, natural-health products, and spiritual therapies 
(Balneaves et al., 2006). An alternative and 
comprehensive approach is distinct in that the evaluation 
of each woman lends a great deal of attention not only to 
individual symptoms, but also to her individual risks for 
future diseases (Hudson, 2008). Approximately 41% of 
women are utilizing CAM forms of medicine to manage 
their BC, including products from the Morinda citrifolia 
(Noni) plant (Clafshenkel  et  al.,  2012).  Complementary 
and Holistic Medicine using MAPs have become 
significant in BC treatment and prevention. Numerous 
studies (128 out of 135 dietary studies) indicated that 
increased vegetable and fruit consumption by humans 
significantly reduced the risk of BC (Borek, 2010). 
 
Vegetables and fruits 
 
Vegetable and fruits have a high content of healthy 
components as vitamins, minerals, and fibers. 
Epidemiological evidence supports a diet rich in whole 
fruits and vegetables in the prevention of fibrocystic 
breast conditions. An international review estimated that 
increased fruit and vegetable consumption could prevent 
5-12% of worldwide cancer burden (Table 5) (Hudson, 
2008; Irimie et al., 2010). 
Although a systematic review of fruit and vegetable 
consumption interventions has shown that face-to-face 
methods are most effective, telephone counselling is 
seen as an effective alternative and behaviour change 
tool for fruit and vegetable consumption in both healthy 
and ill people, with reported long-term success (up to 4 
years) in a randomized trial of BC survivors (Yeh et al., 
2010). 
In China, ‗kiwifruit‘ is widely used for plants in the 
genus Actinidia Lindl., and the fruit they produce. In 
Actinidia  species, mihoutao   are  used  to  treat  BC  and  
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Table 5. Frequency of different food consumption (Irimie et al., 2010). 
 
Category More times/day % Once/day % 2-3 times/week % Once/week % Less frequent % 
Fruits  30.6 22.22 39.68 3.17 4.76 
Vegetables  19.05 20.63 44.44 7.94 7.44 
Saturated fats  1.59 9.52 26.98 19.05 42.86 
Vegetable fats  10.64 27.66 38.30 21.28 2.13 
White meat  7.81 32.81 45.31 7.81 6.25 
Red meat 1.85 46.30 38.89 11.11 1.85 
Fried meat  3.13 4.69 35.94 20.31 35.94 
Diary products  11.11 14.29 44.44 17.46 12.70 
 
 
 
Table 6. The practice of CAM, alternative and complementary medicine by cancer type (Malak et al., 2009). 
 
Cancer site 
Complementary and Alternative 
Medicine (CAM) 
Alternative Therapy 
(AT) 
Complementary Medicine 
(CM) 
User Non-user User User 
Breast cancer  13 (100) - 11(84.6) 13 (100) 
Lung cancer  10 (83.3) 2 (16.7) 9 (75.0) 6 (50.0) 
Brain cancer  6 (85.8) 1 (14.2) 5 (71.4) 4 (57.1) 
Prostate cancer  3 (60.0) 2 (40.0) 3 (60.0) 3 (60.0) 
Colon cancer  4 (100) - 3 (75.0) 4 (100) 
Pancreatic cancer  3 (100) - 3 (100) 2 (66.6) 
Other  9 (81.9) 2 (18.1) 6 (54.5) 6 (54.5) 
Total  48 (87.2) 7 (12.8) 40 (72.7) 36 (65.5) 
 
 
 
cancers of the digestive system (Hunter et al., 2010; 
Wang and Gleave, 2012). Persea americana Mill (family: 
Lauraceae), commonly known as: ‗avocado‘, ‗avocado 
pear‘, ‗Mexican avocado‘ and so on, is a medium-sized, 
single-stemmed, terrestrial, erect, perennial, deciduous, 
evergreen tree of 15-20 m in height. The leaves and 
other morphological parts of P. americana possess 
medicinal properties, and are widely used in traditional 
medicines of many African countries. In Nigeria, the 
leaves of P. americana have been used as an effective 
antitussive, antidiabetic, antihypertensive; and as 
analgesic and anti-inflammatory remedies. The root bark 
of P. americana (RPA) extract includes chemical 
compounds with estrogen-like activity and validates its 
potential use as anticancer agent, particularly against 
breast carcinoma, provided important information is 
potentially helpful in drug designing and discovery. RPA 
demonstrated a significant (P < 0.05) anti-proliferative 
activity against estrogen receptor positive breast cancer 
cell lines (MCF-7) (Engel et al., 2011). Vinblastine and 
vincristine are primarily used in combination with other 
cancer chemotherapeutic drugs for treating breast and 
lung cancers (Shoeb, 2006). Malak et al. (2009) reported 
in their study that 87.2% (n: 48) patients practiced CAM. 
72.7% of the patients practicing CAM applied alternative 
therapy and 65.5% applied complementary therapy. CAM 
practice had been determined in all patients with BC (n: 
13) as reflected in Table 6. 
Wearing a bra less than 12 h per day improved the risk 
to one out of 152, a rate reasonably close to women who 
wear bras rarely or never; they have a one out of 168 
chance of BC. A tight bra blocks the lymph circulation in 
the breasts and is much worse than a loose-fitting bra 
(Last, 2010). This paper presents an ethnobotanical 
survey of MAPs-based foods for effective BC treatment. 
 
METHODS 
 
The major risk factors for BC were gathered and codified 
from 70 orthodox medical practitioners and textbooks. 
Questionnaires followed by face-to-face interviews were 
randomly administered to the 70 physicians from 
February 2009 to June 2012. Specific ethnobotanical 
data on medicinal plants having anticancer properties 
were randomly collected, recorded, and discussed 
through personal contacts in the field, local markets 
(elewe-omo), CAM practitioners, and community leaders. 
500 CAM practitioners in Akure, Idanre, Ondo, Owo, and 
Supare towns in Ondo State of Nigeria who know and 
use MAPs for treating various diseases were interviewed 
using randomly administered semi-structured interview 
technique.   The   interviewers   were   taken   on   guided  
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Figure 2. Guided field-work on MAP data collection. 
 
 
 
fieldworks through the areas where informants collected 
MAPs. MAP uses were discussed in detail with 
informants, after seeking prior informed consent from 
each respondent as exemplified in Figure 2. 
Similar questionnaire method had been used by 
Moschèn et al. (2001), Patterson et al. (2002), Rakovitch 
et al. (2005), Hann et al. (2006) and Fasching et al. 
(2007) cited by Wanchai et al. (2010). Odugbemi (2010) 
shown in Figure 3 had also employed a similar method. 
Additional data on MAPs were also collected from other 
published literature sources including Amusan (2010), 
Christian (2009), Dama et al. (2010), Dog (2010), 
Hywood (2010), Idu et al. (2010), NNMDA (2010), 
Olowokudejo et al. (2008), Rao et al. (2011) and WHO 
(2009); phytochemical databases; reputably cognate 
internet-based MAPs‘ sources; and internet peer-
reviewed articles from NCCAM, EBSCO, SCOPUS, Web 
of Science, SCIELO, Medline, Google scholar, and 
PubMed databases using BC-related keywords. BC-
related search keywords included ―breast cancer‖, 
―women‘s health and cancer‖, ―cancer-related morbidity‖, 
―cancer treatment with phytotherapy‖, ―CAM and breast 
cancer‖, ―alternative treatment/therapies and breast 
cancer‖, and ―complementary and breast cancer‖, etc. To 
ensure that studies focused specifically on women with 
breast cancer, the authors retrieved documents that 
contained the words breast cancer patients or women 
with  breast  cancer   within  their  titles  or   abstracts   as 
adopted by Wanchai et al. (2010). Adverse reactions of 
each MAP for BC treatment were documented. 
 
RESULTS 
 
BC‘s major risk factors include earlier menarche, 
woman‘s age, overweight, hormone replacement therapy, 
eating high-fat diet, wearing a tight bra always, infertility, 
having the first child after age 35, and having dense 
breasts. The assembled MAPs‘ species belonged to 102 
families where Leguminosae family topped the frequency 
table with 22 entries as shown in Table 7 and Figures 4 
and 5. It was observed that 10% of the surveyed MAPs 
yielded Adzuki bean (Phaseolus angularis), Alfalfa 
(Medicago sativa), Asparagus (Asparagus officinalis), 
Avocado pear (Persea Americana), Broccoli (Brassica 
oleracea var. italica), Burdock (Arctium lappa), Cabbage 
(Brassica oleracea var. capitata), Chinese yam 
(Dioscorea alata), Dandelion (Taraxacum officinale), Noni 
(Morinda citrifolia), Onion (Allium cepa), and Tomato 
(Lycopersicon esculentum) in effectively treating BC in 
Nigeria. 
Watercress (Nasturtium officinale, Rorippa nasturtium-
aquaticum) and Watermelon (Citrullus vulgaris, C. 
lanatus) were listed to stop the menace of BC and 
hypertension.  
Anticancer compounds found in vegetables include 
lycopene in tomatoes; lutein and beta-carotene in carrots,  
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al. 2007 cited by Wanchai et al. 2010. Odugbemi (2010) shown in Figure 3 had 
also employed a similar method. 
 
 
 
 
 
 
 
 
                          (a)  Medicinal Plant farm        (b) Guided Field-Walk 
 
 
 
Figure 3. Medicinal_plants_in_Nigeria.com (Odugbemi, 2010). 
 
 
 
Table 7. Collected breast cancer-related medicinal and aromatic plants (MAPs). 
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African 
custard apple 
Abo  Root, 
bark, 
leaves, 
seeds 
Cancer, dysentery, 
cough, venereal 
diseases, 
toothache, 
astringent, 
anthelmintic, ease 
labour, eye drops, 
tumour out growth, 
ant-bee sting 
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Arctium lappa  Burdock   breast cancer   
        
Asparagus 
officinalis 
 Asparagus  Roots breast cancer  Dama et al. 
2010 
        
Brassica oleracea 
var. capitata 
 Cabbage   breast cancer   
        
Brassica oleracea 
var. italica 
 Broccoli   breast cancer   
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Resurrection 
plant, life 
plant 
Eru-odundun, 
Abamoda  
Leaves, 
roots, leaf 
sap 
Cough, diarrhoea, 
dysentery, 
wounds, fever, 
sedative, diuretic, 
epilepsy, 
antifungal, 
antimicrobial, 
anticancer 
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Table 7. Contd. 
 
Carica papaya Caricaceae Pawpaw Ibepe  Leaves, 
fruits, 
seeds 
With the bark of 
Mangifera indica to 
cure malaria; 
gonorrhoea, 
syphilis, amoebic 
dysentery, 
diabetes, mental 
disorder, 
convulsion; papain 
as meat tendirizer 
and as digester in 
breweries. 
 
 
        
Citrullus vulgaris, 
C. lanatus 
 Watermelon Egusi-baara  breast cancer 
 
 
Dioscorea alata  Chinese yam     breast cancer   
G
a
rc
in
ia
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o
la
 
Guttiferae Bitter cola Orogbo  Seeds, 
root, 
stem-
bark, 
fruits 
Dysentery, 
bronchitis, cough, 
fever, toothache, 
throat and 
respiratory 
ailments, liver 
disorders, 
headache, 
anticancer. 
 
O
lo
w
o
k
u
d
e
jo
 e
t 
a
l.
 
2
0
0
8
 
        
Habenaria 
roxburghii (Pers.) 
R.Br.  
Orchidaceae    Tuber 
paste 
 Breast cancer   
        
Hedera nepalensis 
K.Koch [Da Wano 
Kalay] 
Araliaceae   Leaves  Anticancer 
Artemisia brevifolia 
 Hamayun 
et al. 2006 
        
Lycopersicon 
esculentum 
 Tomato   breast cancer   
        
Morinda citrifolia  Noni  Fruits, 
roots, 
bark, 
stems, 
flowers 
leaves (all 
parts)  
breast cancer, 
infection, arthritis, 
diabetes, asthma, 
hypertension, and 
pain 
 
Dama et al. 
2010 
        
Nasturtium 
officinale, Rorippa 
nasturtium-
aquaticum 
 Watercress   breast cancer 
 
 
        
Persea americana 
(RPA) 
Lauraceae Avocado 
pear 
 Root Breast cancer, 
threatened 
abortion, ulcer 
 Engel et al. 
2011 
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Phaseolus 
angularis 
 Adzuki bean   breast cancer   
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 African rose 
wood 
Gbingbin, Imo-
osun, Apepo, 
Agbelosun 
Leaves, 
stem-bark 
Insomnia,  
dysentery, 
dermatomycosis, 
breast cancer 
fever, diarrhoea 
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 Apepo, 
Agbelosun 
Leaves, 
stem-bark 
Insomnia, 
dermatomycosis, 
breast cancer 
fever, dysentery, 
diarrhoea 
  
        
Taraxacum 
officinale 
 Dandelion   breast cancer   
        
Vernonia colorata Asteraceae Bitter tree Eriro-Ijebu  Root, 
leaves 
Antipyretic, 
antihelmintic, 
astringent; skin 
diseases, 
gonorrhoea, 
anaemia, poison 
antidote, prostrate 
cancer, loss of 
memory, stroke 
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Viola biflora L. 
[Banafsha] 
Violaceae   Flower  Diaphoretic, 
antipyretic, 
febrifuge, cancer, 
epilepsy and 
nervous disorders 
 Hamayun 
et al. 2006 
        
Viola canescens 
Wall. ex Roxb 
[Banafsha] 
Violaceae   Whole 
plant  
 Astringent, 
demulcent, 
purgative, 
diaphoretic, 
antipyretic, 
febrifuge and anti 
cancerous 
 Hamayun 
et al. 2006 
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Mistletoe Afomo  Whole 
plant 
All purpose herb 
for cancer, 
anaemia, HBP, 
diabetes, stroke, 
hysteria, 
amenorrhoea, 
Infertility, 
dysmenorrhoea; 
emetic. 
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diseases, cough, 
tuberculosis, 
cancers, urinary 
disorders, arthritis, 
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Common 
Ginger 
Jinja, Atale, 
Atalekopa, Lali-
funfun 
  
Rhizome, 
Root 
 Cold, cough, 
asthma, cholera  
stimulant, 
rheumatism, piles, 
hepatitis, liver 
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Figure 4. Watermelon and other fruits‘ hawker, Lagos, Nigeria. 
 
 
 
pumpkin, and squash; and allyl sulfides in onions and 
garlic; and sulforaphane in broccoli, cabbage and 
Brussels sprouts. BC constituted 10% of the prevalent 
diseases treated with MAPs (Figure 6). 
The database of a previously developed software by 
this author (Multimedia-based Medicinal Plants 
Sustainability Management System - MMPSMS) to 
address MAPs‘ extinction challenge was populated with 
the discovered vegetables and fruits using the interfaces 
shown in Figure 7. 
Figure 8 shows the video of the salient details of a 
retrieved plant, Zingiber officinale Rosc (Common 
Ginger)  for  treating  asthma,  stimulant,  piles,  hepatitis, 
liver diseases, obesity, typhoid, anaemia, cancer, 
dysentery, dysmenorrhoea, etc., which could be viewed, 
and its audio feature played. 
Morinda citrifolia‘s fruits, roots, bark, stems, flowers and 
leaves (in fact, all parts) have become renowned for 
handling breast cancer, infection, arthritis, diabetes, 
asthma, hypertension, and pain. Little wonder as when 
approximately 41% of women utilizing CAM forms of 
medicine to manage their BC include products from the 
Morinda citrifolia (Noni) plant. Morinda citrifolia‘s 
efficacious distinction has made it being planted by 
several people around their residence as shown in Figure 
9. 
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Figure 5. Medicinal_Plants versus Diseases_Treated Matrix. 
 
 
 
 
 
Figure 6. Patients Prevalent Diseases Treated with MAPs. 
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Figure 7. Multimedia-based medicinal plants sustainability management system (MMPSMS) interface. 
 
 
 
 
 
Figure 8. Enquiry from MMPSMS showing diseases treated with a plant. 
 
 
 
Conclusion 
 
BC, an important and potentially fatal condition, is 
associated with both genetic and non-genetic risk factors. 
Wearing a tight bra always blocks the lymph circulation in 
the breasts thereby increasing BC risk. Orthodox BC 
treatments have devastating effects including temporary 
infertility.  Women  with  breast  cancer  seek  CAM  more  
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Figure 9. Morinda citrifolia (Noni) around residence. 
 
 
 
than other patient populations with cancer. BC patients 
should take several portions of macrobiotic diet daily, 
while nutritional antioxidant effects on immune functions 
in relation to the pathogenesis of cancer and 
atherosclerosis deserve increased research effort, given 
their effect on mortality and morbidity. Although botanical 
gardens used to ensure sustainable availability of 
efficacious medicinal and aromatic plants in treating 
ailments and diseases are established, other barriers 
impeding acceptance of CAM into conventional 
healthcare delivery system should be identified and 
overcome. A Board of Traditional Medicine Practitioners 
(BTMP) under each State‘s Ministry of Health should be 
established to regulate the practice of biologically-based 
phytomedicine by CAM practitioners. Researches for a 
paradigmatic approach to CAM integration that could 
create a common basis for scientific dialogue, encourage 
exchanges between medical communities, and establish 
policies for the development of a true multidisciplinary 
health care cooperative that is consistent with the current 
public health model should be encouraged and funded by 
governments. 
Digitization of the MAPs achieved in this project would 
help health care providers and decision-makers make 
informed clinical and management decisions based on 
evidence, so they could choose care appropriate to the 
individual, and share knowledge and experience. Data 
mining and data warehousing capabilities that would give 
health managers new knowledge and insights into a wide 
range of health trends and enable them to manage 
resources better would be facilitated by this research 
effort. Health care professionals would have access to 
more data on prevention, health hazards and diseases, 
and be better equipped to understand the impact of 
lifestyle, environmental hazards and socioeconomic 
status on the health of the population. More health and 
healthcare researches would be needed in order to 
reduce the uncertainty associated with the diagnosis, 
treatment and delivery of health care to all of the people 
in our society who are in need of it. 
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